Nano News

Looking inside Nanolive

Nanolive at Basel Life MipTec 2019 – September 10 to 12

Nanolive will be exhibiting at Basel Life MipTec 2019 from September 10 to 12. We would be happy to see you at our booth D10 and discuss with you label-free live cell imaging solutions. We will be participating in the following events:Industry Symposium Session title:...

read more

Protrusions in Human Umbilical Vein Endothelial Cells

Endothelial cells, as mentioned in our previous blogpost (https://nanolive.ch/failed-mitotic-exit-in-human-umbilical-vein-endothelial-cells/), constitute the inner layer of blood and lymphatic vessels. They also play a role in substance and cell turnover between...

read more

Failed mitotic exit in Human Umbilical Vein Endothelial Cells

Human Umbilical Vein Endothelial Cells (HUVECs) were first cultured in 1973[1]. Since then, their isolation protocols have improved and they have become a model system for the study of a variety of vascular pathologies, such as inflammatory disease, atherosclerosis...

read more

Nanolive holds its first global distributor meeting

Last month, Nanolive invited to its first global distributor meeting. Our partners from USA, Japan, Australia, China, Taiwan, South Korea, India, Turkey, Russia, Israel, Italy, Nordics, Croatia, Czech Republic, Poland, UK came to participate to meetings, workshops and...

read more

Scientists of Tomorrow 2019: The Verdict

The second edition of our Scientists of Tomorrow contest for undergraduate students brought us many applications from all over the world. Nanolive wants to thank all the participants for taking part in this year’s contest. We are overwhelmed by the amount and...

read more

Nanolive at ISSCR from 26-29 June – Los Angeles

Join Nanolive and our partner Nexus at Booth #SUP8 at ISSCR in Los Angeles next week from 26-29 June.  The conference will be held at the Lost Angeles Convention Center, California, USA. For more information, visit their website:...

read more

ADC Trigger Selective Cancer Cell Death

Chemotherapy has been used to treat cancer for almost 80 years now[1] and its side effects are well known and documented. One of the main limitations associated with standard chemotherapy is the unspecific killing of healthy cells (e.g. rapidly dividing cells in the...

read more

From one to two: cytokinesis in mesenchymal stem cells

Cytokinesis, as we briefly introduced in our mitosis in Mesenchymal Stem Cells post, refers to the obtention of two separated daughter cells after mitosis[1]. The process of separation can coincide in time with anaphase and/or telophase, the two final steps in...

read more

New publication of the Justus-Liebig University of Giessen

Nanolive is pleased to share a new publication in Nature Scientific Reports from our users in the Justus-Liebig University of Giessen [1]. Besnoitia besnoiti is an emerging parasite in Europe, responsible for bovine besnoitiosis, an illness causing a significant...

read more